A combined targeted/phenotypic approach for the identification of new antiangiogenics agents active on a zebrafish model: from in silico screening to cyclodextrin formulation.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Bioorganic & Medicinal Chemistry Letters

• Publication date

  2012-09-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bmcl.2012.07.014PMID 22853993
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumor microenvironment complexity: emerging roles in cancer therapy.

  2012cited by this paper
• New insights into small‐molecule inhibitors of Bcr‐Abl

  2011cited by this paper
• How were new medicines discovered?

  2011cited by this paper
• Design, synthesis, biological activity, and ADME properties of pyrazolo[3,4-d]pyrimidines active in hypoxic human leukemia cells: a lead optimization study.

  2011cited by this paper
• Identification of potent c-Src inhibitors strongly affecting the proliferation of human neuroblastoma cells.

  2011cited by this paper
• 2-Hydroxypropyl-β-cyclodextrin strongly improves water solubility and anti-proliferative activity of pyrazolo[3,4-d]pyrimidines Src-Abl dual inhibitors.

  2010cited by this paper
• Design and Synthesis of Thiadiazoles and Thiazoles Targeting the Bcr‐Abl T315I Mutant: from Docking False Positives to ATP‐Noncompetitive Inhibitors

  2010cited by this paper
• An overview of small-molecule inhibitors of VEGFR signaling

  2009cited by this paper
• A novel imaging‐based high‐throughput screening approach to anti‐angiogenic drug discovery

  2009cited by this paper
• Pyridyl-pyrimidine benzimidazole derivatives as potent, selective, and orally bioavailable inhibitors of Tie-2 kinase.

  2009cited by this paper
• C6‐Unsubstituted Pyrazolo[3,4‐d]pyrimidines Are Dual Src/Abl Inhibitors Effective against Imatinib Mesylate Resistant Chronic Myeloid Leukemia Cell Lines

  2009cited by this paper
• Discovery and SAR of 1,3,4-thiadiazole derivatives as potent Abl tyrosine kinase inhibitors and cytodifferentiating agents.

  2008cited by this paper
• Antiangiogenic agents: an update on small molecule VEGFR inhibitors.

  2007cited by this paper
• Identification of a novel pyrazolo[3,4-d]pyrimidine able to inhibit cell proliferation of a human osteogenic sarcoma in vitro and in a xenograft model in mice.

  2007cited by this paper
• SRC inhibitors and angiogenesis.

  2007cited by this paper
• Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma.

  2006cited by this paper
• Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer.

  2006cited by this paper
• Pyrazolo[3,4-d]pyrimidines c-Src inhibitors reduce epidermal growth factor-induced migration in prostate cancer cells.

  2006cited by this paper
• Pyrazolo[3,4-d]pyrimidines as potent antiproliferative and proapoptotic agents toward A431 and 8701-BC cells in culture via inhibition of c-Src phosphorylation.

  2006cited by this paper
• SRC family kinase inhibitor SU6656 enhances antiangiogenic effect of irradiation.

  2006cited by this paper
• New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors.

  2006cited by this paper
• Sorafenib for the Treatment of Advanced Renal Cell Carcinoma

  2006cited by this paper
• Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma.

  2006cited by this paper
• Application of pharmaceutical profiling assays for optimization of drug-like properties.

  2005cited by this paper
• Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors.

  2005cited by this paper
• A novel Src kinase inhibitor, M475271, inhibits VEGF-induced human umbilical vein endothelial cell proliferation and migration.

  2005cited by this paper
• [Therapeutic strategies using VEGF inhibitors in colorectal cancer].

  2005cited by this paper
• AP23846, a novel and highly potent Src family kinase inhibitor, reduces vascular endothelial growth factor and interleukin-8 expression in human solid tumor cell lines and abrogates downstream angiogenic processes

  2005cited by this paper
• Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy

  2005cited by this paper
• Pyrazolo[3,4-d]pyrimidines endowed with antiproliferative activity on ductal infiltrating carcinoma cells.

  2004cited by this paper
• Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.

  2004cited by this paper
• Zebrafish: a new model on the pharmaceutical catwalk.

  2003cited by this paper
• Improved protein–ligand docking using GOLD

  2003cited by this paper
• Src-mediated coupling of focal adhesion kinase to integrin αvβ5 in vascular endothelial growth factor signaling

  2002cited by this paper
• Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability.

  1999cited by this paper
• Induction of angiogenesis during the transition from hyperplasia to neoplasia

  1989cited by this paper

• Serum/glucocorticoid regulated kinase 1 (SGK1) in neurological disorders: Pain or gain.

  2024cites this paper
• Caffeine-Cyclodextrin Complexes as Solids: Synthesis, Biological and Physicochemical Characterization †

  2021cites this paper
• Computational Drug Repositioning for Chagas Disease Using Protein-Ligand Interaction Profiling

  2020cites this paper
• Identifying Lysophosphatidic Acid Acyltransferase β (LPAAT‐β) as the Target of a Nanomolar Angiogenesis Inhibitor from a Phenotypic Screen Using the Polypharmacology Browser PPB2

  2018cites this paper
• Identification of Breast Cancer Inhibitors Specific for G Protein‐Coupled Estrogen Receptor (GPER)‐Expressing Cells

  2017cites this paper
• Prodrugs of Pyrazolo[3,4-d]pyrimidines: From Library Synthesis to Evaluation as Potential Anticancer Agents in an Orthotopic Glioblastoma Model.

  2017cites this paper
• Fishing anti(lymph)angiogenic drugs with zebrafish.

  2017cites this paper
• Human iPSC-derived endothelial cell sprouting assay in synthetic hydrogel arrays.

  2016cites this paper
• Development and in Vitro Evaluation of a Microbicide Gel Formulation for a Novel Non-Nucleoside Reverse Transcriptase Inhibitor Belonging to the N-Dihydroalkyloxybenzyloxopyrimidines (N-DABOs) Family.

  2016cites this paper
• Improvement of pyrazolo[3,4-d]pyrimidines pharmacokinetic properties: nanosystem approaches for drug delivery

  2016cites this paper
• Advancing Toxicology Research Using In Vivo High Throughput Toxicology with Small Fish Models

  2016cites this paper
• Heparin Inhibits Proliferation and Migration of Patient-Derived Vascular Cells Only at Non-physiological Concentrations Due to Antagonistic Pathways

  2016cites this paper
• Pyrazoles as potential anti-angiogenesis agents: a contemporary overview

  2014cites this paper
• CYP-dependent metabolism of antitumor pyrazolo[3,4-d]pyrimidine derivatives is characterized by an oxidative dechlorination reaction.

  2014cites this paper
• Src inhibition potentiates antitumoral effect of paclitaxel by blocking tumor-induced angiogenesis.

  2014cites this paper
• Hooking the big one: the potential of zebrafish xenotransplantation to reform cancer drug screening in the genomic era

  2014cites this paper
• Zebrafish model in drug safety assessment.

  2014cites this paper
• Intimal Hyperplasia. Experimental and Clinical Studies

  2014cites this paper
• Use of Zebrafish Embryos for Small Molecule Screening Related to Cancer

  2013cites this paper
• Use of zebrafish in chemical biology and drug discovery.

  2013cites this paper
• Regio- and stereoselective synthesis of spirooxindole 1'-nitro pyrrolizidines with five concurrent stereocenters under aqueous medium and their bioprospection using the zebrafish (Danio rerio) embryo model.

  2013cites this paper
• Pyrazolo[3,4-d]pyrimidine Prodrugs: Strategic Optimization of the Aqueous Solubility of Dual Src/Abl Inhibitors.

  2013cites this paper